Global Pneumonia Therapeutics Industry

Global Pneumonia Therapeutics Market to Reach US$22. 5 Billion by the Year 2027. Amid the COVID-19 crisis, the global market for Pneumonia Therapeutics estimated at US$14. 5 Billion in the year 2020, is projected to reach a revised size of US$22.

New York, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Pneumonia Therapeutics Industry" - https://www.reportlinker.com/p05957705/?utm_source=GNW
5 Billion by 2027, growing at a CAGR of 6.5% over the analysis period 2020-2027.Drugs, one of the segments analyzed in the report, is projected to grow at a 2.7% CAGR to reach US$5.6 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Vaccines segment is readjusted to a revised 8.3% CAGR for the next 7-year period. This segment currently accounts for a 63.1% share of the global Pneumonia Therapeutics market.

The U.S. Accounts for Over 29.5% of Global Market Size in 2020, While China is Forecast to Grow at a 6.2% CAGR for the Period of 2020-2027

The Pneumonia Therapeutics market in the U.S. is estimated at US$4.3 Billion in the year 2020. The country currently accounts for a 29.45% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$4 Billion in the year 2027 trailing a CAGR of 6.2% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.6% and 5.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR while Rest of European market (as defined in the study) will reach US$4 Billion by the year 2027.

Oxygen Therapy Segment Corners a 4.7% Share in 2020

In the global Oxygen Therapy segment, USA, Canada, Japan, China and Europe will drive the 4.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$544.8 Million in the year 2020 will reach a projected size of US$733 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.6 Billion by the year 2027.We bring years of research experience to this 5th edition of our report. The 133-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

• Abbott Laboratories

• Allergan PLC

• Bayer AG

• GlaxoSmithKline PLC

• Lupin Pharmaceuticals, Inc.

• Merck & Co., Inc.

• Novartis AG

• Pfizer, Inc.

Read the full report: https://www.reportlinker.com/p05957705/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Pneumonia Therapeutics Competitor Market Share Scenario
Worldwide (in %): 2018E

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Pneumonia
Therapeutics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2018 through
2027

Table 2: World Historic Review for Pneumonia Therapeutics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2017

Table 3: World 15-Year Perspective for Pneumonia Therapeutics
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2012, 2018 & 2027

Table 4: World Current & Future Analysis for Drugs by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2018 through 2027

Table 5: World Historic Review for Drugs by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Billion for Years 2012 through 2017

Table 6: World 15-Year Perspective for Drugs by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2018 & 2027

Table 7: World Current & Future Analysis for Vaccines by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2018 through 2027

Table 8: World Historic Review for Vaccines by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Billion for Years 2012 through 2017

Table 9: World 15-Year Perspective for Vaccines by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2018 & 2027

Table 10: World Current & Future Analysis for Oxygen Therapy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2018 through 2027

Table 11: World Historic Review for Oxygen Therapy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2017

Table 12: World 15-Year Perspective for Oxygen Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Pneumonia Therapeutics Market Share (in %) by Company: 2018
& 2027
Market Analytics
Table 13: USA Current & Future Analysis for Pneumonia
Therapeutics by Product Type - Drugs, Vaccines and Oxygen
Therapy - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027

Table 14: USA Historic Review for Pneumonia Therapeutics by
Product Type - Drugs, Vaccines and Oxygen Therapy Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017

Table 15: USA 15-Year Perspective for Pneumonia Therapeutics by
Product Type - Percentage Breakdown of Value Sales for Drugs,
Vaccines and Oxygen Therapy for the Years 2012, 2018 & 2027

CANADA
Table 16: Canada Current & Future Analysis for Pneumonia
Therapeutics by Product Type - Drugs, Vaccines and Oxygen
Therapy - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027

Table 17: Canada Historic Review for Pneumonia Therapeutics by
Product Type - Drugs, Vaccines and Oxygen Therapy Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017

Table 18: Canada 15-Year Perspective for Pneumonia Therapeutics
by Product Type - Percentage Breakdown of Value Sales for
Drugs, Vaccines and Oxygen Therapy for the Years 2012, 2018 &
2027

JAPAN
Table 19: Japan Current & Future Analysis for Pneumonia
Therapeutics by Product Type - Drugs, Vaccines and Oxygen
Therapy - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027

Table 20: Japan Historic Review for Pneumonia Therapeutics by
Product Type - Drugs, Vaccines and Oxygen Therapy Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017

Table 21: Japan 15-Year Perspective for Pneumonia Therapeutics
by Product Type - Percentage Breakdown of Value Sales for
Drugs, Vaccines and Oxygen Therapy for the Years 2012, 2018 &
2027

CHINA
Table 22: China Current & Future Analysis for Pneumonia
Therapeutics by Product Type - Drugs, Vaccines and Oxygen
Therapy - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027

Table 23: China Historic Review for Pneumonia Therapeutics by
Product Type - Drugs, Vaccines and Oxygen Therapy Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017

Table 24: China 15-Year Perspective for Pneumonia Therapeutics
by Product Type - Percentage Breakdown of Value Sales for
Drugs, Vaccines and Oxygen Therapy for the Years 2012, 2018 &
2027

EUROPE
Market Facts & Figures
European Pneumonia Therapeutics Market: Competitor Market Share
Scenario (in %) for 2018 & 2027
Market Analytics
Table 25: Europe Current & Future Analysis for Pneumonia
Therapeutics by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2018 through 2027

Table 26: Europe Historic Review for Pneumonia Therapeutics by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Billion for Years 2012 through 2017

Table 27: Europe 15-Year Perspective for Pneumonia Therapeutics
by Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2012, 2018 & 2027

Table 28: Europe Current & Future Analysis for Pneumonia
Therapeutics by Product Type - Drugs, Vaccines and Oxygen
Therapy - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027

Table 29: Europe Historic Review for Pneumonia Therapeutics by
Product Type - Drugs, Vaccines and Oxygen Therapy Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017

Table 30: Europe 15-Year Perspective for Pneumonia Therapeutics
by Product Type - Percentage Breakdown of Value Sales for
Drugs, Vaccines and Oxygen Therapy for the Years 2012, 2018 &
2027

FRANCE
Table 31: France Current & Future Analysis for Pneumonia
Therapeutics by Product Type - Drugs, Vaccines and Oxygen
Therapy - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027

Table 32: France Historic Review for Pneumonia Therapeutics by
Product Type - Drugs, Vaccines and Oxygen Therapy Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017

Table 33: France 15-Year Perspective for Pneumonia Therapeutics
by Product Type - Percentage Breakdown of Value Sales for
Drugs, Vaccines and Oxygen Therapy for the Years 2012, 2018 &
2027

GERMANY
Table 34: Germany Current & Future Analysis for Pneumonia
Therapeutics by Product Type - Drugs, Vaccines and Oxygen
Therapy - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027

Table 35: Germany Historic Review for Pneumonia Therapeutics by
Product Type - Drugs, Vaccines and Oxygen Therapy Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017

Table 36: Germany 15-Year Perspective for Pneumonia
Therapeutics by Product Type - Percentage Breakdown of Value
Sales for Drugs, Vaccines and Oxygen Therapy for the Years
2012, 2018 & 2027

ITALY
Table 37: Italy Current & Future Analysis for Pneumonia
Therapeutics by Product Type - Drugs, Vaccines and Oxygen
Therapy - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027

Table 38: Italy Historic Review for Pneumonia Therapeutics by
Product Type - Drugs, Vaccines and Oxygen Therapy Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017

Table 39: Italy 15-Year Perspective for Pneumonia Therapeutics
by Product Type - Percentage Breakdown of Value Sales for
Drugs, Vaccines and Oxygen Therapy for the Years 2012, 2018 &
2027

UNITED KINGDOM
Table 40: UK Current & Future Analysis for Pneumonia
Therapeutics by Product Type - Drugs, Vaccines and Oxygen
Therapy - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027

Table 41: UK Historic Review for Pneumonia Therapeutics by
Product Type - Drugs, Vaccines and Oxygen Therapy Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017

Table 42: UK 15-Year Perspective for Pneumonia Therapeutics by
Product Type - Percentage Breakdown of Value Sales for Drugs,
Vaccines and Oxygen Therapy for the Years 2012, 2018 & 2027

REST OF EUROPE
Table 43: Rest of Europe Current & Future Analysis for
Pneumonia Therapeutics by Product Type - Drugs, Vaccines and
Oxygen Therapy - Independent Analysis of Annual Sales in US$
Billion for the Years 2018 through 2027

Table 44: Rest of Europe Historic Review for Pneumonia
Therapeutics by Product Type - Drugs, Vaccines and Oxygen
Therapy Markets - Independent Analysis of Annual Sales in US$
Billion for Years 2012 through 2017

Table 45: Rest of Europe 15-Year Perspective for Pneumonia
Therapeutics by Product Type - Percentage Breakdown of Value
Sales for Drugs, Vaccines and Oxygen Therapy for the Years
2012, 2018 & 2027

ASIA-PACIFIC
Table 46: Asia-Pacific Current & Future Analysis for Pneumonia
Therapeutics by Product Type - Drugs, Vaccines and Oxygen
Therapy - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027

Table 47: Asia-Pacific Historic Review for Pneumonia
Therapeutics by Product Type - Drugs, Vaccines and Oxygen
Therapy Markets - Independent Analysis of Annual Sales in US$
Billion for Years 2012 through 2017

Table 48: Asia-Pacific 15-Year Perspective for Pneumonia
Therapeutics by Product Type - Percentage Breakdown of Value
Sales for Drugs, Vaccines and Oxygen Therapy for the Years
2012, 2018 & 2027

REST OF WORLD
Table 49: Rest of World Current & Future Analysis for Pneumonia
Therapeutics by Product Type - Drugs, Vaccines and Oxygen
Therapy - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027

Table 50: Rest of World Historic Review for Pneumonia
Therapeutics by Product Type - Drugs, Vaccines and Oxygen
Therapy Markets - Independent Analysis of Annual Sales in US$
Billion for Years 2012 through 2017

Table 51: Rest of World 15-Year Perspective for Pneumonia
Therapeutics by Product Type - Percentage Breakdown of Value
Sales for Drugs, Vaccines and Oxygen Therapy for the Years
2012, 2018 & 2027

IV. COMPETITIONES
Total Companies Profiled: 68
Read the full report: https://www.reportlinker.com/p05957705/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001